Counselors in Rupert, ID Accepting Medicare
4 Counselors found. Showing 1 - 4
 Ms. Bonita Jo Anne Frazier-shewmaker, LCPC, LMFT, NCC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 512 6th St, Rupert, ID 83350 Phone: 208-436-4911 Fax: 208-436-1758 |
Jeanette Bern Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 940 N 100 E, Rupert, ID 83350 Phone: 208-260-1212 |
 John B Clayton, ICADC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 1275 N 400 E, Rupert, ID 83350 Phone: 208-271-4363 |
Mikea Barrie, LMSW Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 707 F St, Rupert, ID 83350 Phone: 208-650-3977 |
News Archive
CORD:USE Cord Blood Bank, Memorial Healthcare System announce partnership
CORD:USE Cord Blood Bank announced today that it is partnering with the Memorial Healthcare System, the fifth-largest public healthcare system in the nation, to collect umbilical cord blood that will be placed in a global registry for patients in need of a potentially life-saving transplant.
Mesupron could extend progression-free survival for metastatic breast cancer patients
Previous research has shown that a family of genes, proteins and enzymes called the uPA system (for urokinase plasminogen activator) plays an active role in different facets of cancer's biology, including tumor cell invasion, the spread of metastases, and the growth of a primary tumor. Mesupron- is a new small molecule inhibitor, taken as a pill, that inhibits the uPA system.
Patent analysis reveals that saffron bioactives can be used to treat multiple disorders
Increased stress levels, sleep disorders and obesity have become hallmarks of present lifestyle. These conditions are often correlated with serious health problems such as cancer, diabetes, cerebral ischemia, stroke, etc.
More AIDS-defining illnesses and severe side effects occur with appropriate comparator therapy
The drug combination of elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil (elvitegravir fixed combination, trade name: Stribild) has been approved in Germany since May 2013 for the treatment of adults infected with human immunodeficiency virus type 1 (HIV-1).
› Verified 4 days ago